残余胆固醇与心血管疾病风险的研究现状  

Research status of remnant cholesterol and cardiovascular disease risk

作　　者：陈焱 徐清 周庆志 陈胜岳 吕志博 赵昕[1] CHEN Yan;XU Qing;ZHOU Qingzhi;CHEN Shengyue;LYU Zhibo;ZHAO Xin(Department of Cardiovascular Medicine,the Second Affiliated Hospital of Dalian Medical University,Dalian,Liaoning 116027,China;Graduate School of Jinzhou Medical University,Jinzhou,Liaoning 121000,China)

机构地区：[1]大连医科大学附属第二医院心血管内科,辽宁省大连市116027 [2]锦州医科大学研究生院,辽宁省锦州市121000

出　　处：《中国动脉硬化杂志》2022年第7期640-644,共5页Chinese Journal of Arteriosclerosis

基　　金：科技部国家重点研发计划“主动健康和老龄化科技应对”重点专项(2020YFC2004701)。

摘　　要：残余胆固醇(remnant cholesterol,RC)所趋使的残余风险近来被欧美等国家高度重视。相比于传统血脂四项(低密度脂蛋白胆固醇、总胆固醇、甘油三酯、高密度脂蛋白胆固醇),RC在动脉粥样硬化性心脏病、支架内再狭窄、主动脉瓣狭窄等多种心血管疾病中有着非常重要的预测价值,并且这种预测价值是独立于传统血脂四项的。重视及调控残余胆固醇水平对于改善这些心血管疾病患者的预后具有重要意义。The residual risk of remnant cholesterol(RC)has been highly valued by Europe and the United States recently.Compared with the traditional four blood lipids(low-density lipoprotein cholesterol,total cholesterol,triglyceride,high-density lipoprotein cholesterol),remnant cholesterol has a very important predictive value in various cardiovascular diseases such as atherosclerotic heart disease,in-stent restenosis,and aortic stenosis,and this predictive value is independent of the traditional four blood lipids.Attaching importance to and regulating remnant cholesterol levels is very necessary to improve the prognosis of cardiovascular disease.

关 键 词：残余胆固醇 冠状动脉粥样硬化性心脏病 富含甘油三酯脂蛋白 危险因素 

分 类 号：R5[医药卫生—内科学]